Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

854 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.
Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Ziya Gencer M, Ammari A, Sadeghi A, Roshangar L, Aslani S, Esmaeilzadeh A, Ghaebi M, Valizadeh S, Ahmadi M. Valizadeh H, et al. Among authors: sadeghi a. Int Immunopharmacol. 2020 Dec;89(Pt B):107088. doi: 10.1016/j.intimp.2020.107088. Epub 2020 Oct 20. Int Immunopharmacol. 2020. PMID: 33129099 Free PMC article. Clinical Trial.
Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.
Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Taghizadieh A, Nazemiyeh M, Aghebati-Maleki L, Jadidi-Niaragh F, Abbaspour-Aghdam S, Roshangar L, Mikaeili H, Ahmadi M. Sadeghi A, et al. J Cell Physiol. 2021 Apr;236(4):2829-2839. doi: 10.1002/jcp.30047. Epub 2020 Sep 14. J Cell Physiol. 2021. PMID: 32926425
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L. Tahmasebi S, et al. Among authors: sadeghi a. Life Sci. 2021 Jul 1;276:119437. doi: 10.1016/j.lfs.2021.119437. Epub 2021 Mar 28. Life Sci. 2021. PMID: 33789145 Free PMC article.
Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.
Abbaspour-Aghdam S, Hazrati A, Abdolmohammadi-Vahid S, Tahmasebi S, Mohseni J, Valizadeh H, Nadiri M, Mikaeili H, Sadeghi A, Yousefi M, Roshangar L, Nikzad B, Jadidi-Niaragh F, Kafil HS, Malekpour K, Ahmadi M. Abbaspour-Aghdam S, et al. Among authors: sadeghi a. Eur J Pharmacol. 2022 Oct 15;933:175267. doi: 10.1016/j.ejphar.2022.175267. Epub 2022 Sep 17. Eur J Pharmacol. 2022. PMID: 36122756 Free PMC article. Clinical Trial.
Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial.
Moslemi M, Hejazian SM, Shaddelan M, Javanali F, Mirghaffari A, Sadeghi A, Valizadeh H, Sharifi A, Haramshahi M, Ardalan M, Zununi Vahed S. Moslemi M, et al. Among authors: sadeghi a. Inflammopharmacology. 2022 Aug;30(4):1277-1282. doi: 10.1007/s10787-022-01001-2. Epub 2022 Jun 20. Inflammopharmacology. 2022. PMID: 35723849 Free PMC article. Clinical Trial.
Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools.
Abbaszadeh H, Ghorbani F, Abbaspour-Aghdam S, Kamrani A, Valizadeh H, Nadiri M, Sadeghi A, Shamsasenjan K, Jadidi-Niaragh F, Roshangar L, Ahmadi M. Abbaszadeh H, et al. Among authors: sadeghi a. Stem Cell Res Ther. 2022 Jun 20;13(1):262. doi: 10.1186/s13287-022-02938-5. Stem Cell Res Ther. 2022. PMID: 35725505 Free PMC article. Review.
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial.
Rashidi F, Barco S, Rezaeifar P, Sadeghipour P, Ghodrati S, Bakhshandeh H, Mousavi-Aghdas SA, Sadeghi A, Sharifi A, Valizadeh H, Mikaeili H, Rafiee F, Navarbaf Z, Farajian G, Mahmoodpoor A, Bikdeli B, Ansarin K. Rashidi F, et al. Among authors: sadeghi a. Thromb Res. 2022 Aug;216:125-128. doi: 10.1016/j.thromres.2021.12.003. Epub 2021 Dec 7. Thromb Res. 2022. PMID: 34969528 Free PMC article. Clinical Trial. No abstract available.
Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial.
Nouri-Vaskeh M, Kalami N, Zand R, Soroureddin Z, Varshochi M, Ansarin K, Rezaee H, Taghizadieh A, Sadeghi A, Ahangari Maleki M, Esmailnajad A, Saleh P, Haghdoost M, Maleki M, Sharifi A. Nouri-Vaskeh M, et al. Among authors: sadeghi a. Int J Clin Pract. 2021 Jun;75(6):e14124. doi: 10.1111/ijcp.14124. Epub 2021 Mar 13. Int J Clin Pract. 2021. PMID: 33650197 Free PMC article. Clinical Trial.
854 results